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Abstract: The major hemodynamic benefits of intra-aortic
balloon pump (IABP) counterpulsation are augmentation
in diastolic aortic pressure (Paug) during inflation, and
decrease in end-diastolic aortic pressure (DedP) during
deflation. When the patient is nursed in the semirecumbent
position these benefits are diminished. Attempts to change
the shape of the IAB in order to limit or prevent this deteri-
oration have been scarce. The aim of the present study was
to investigate the hemodynamic performance of six new
IAB shapes, and compare it to that of a traditional cylindri-
cal IAB. A mock circulation system, featuring an artificial
left ventricle and an aortic model with 11 branches and
physiological resistance and compliance, was used to test
one cylindrical and six newly shaped IABs at angles 0, 10,
20, 30, and 408. Pressure was measured continuously at the
aortic root during 1:1 and 1:4 IABP support. Shape 2 was
found to consistently achieve, in terms of absolute magni-
tude, larger DedP at angles than the cylindrical IAB.
Although DedP was gradually diminished with angle, it did
so to a lesser degree than the cylindrical IAB; this diminish-
ment was only 53% (with frequency 1:1) and 40% (with
frequency 1:4) of that of the cylindrical IAB, when angle
increased from 0 to 408. During inflation Shape 1 displayed
a more stable behavior with increasing angle compared to
the cylindrical IAB; with an increase in angle from 0 to 408,
diastolic aortic pressure augmentation dropped only by
45% (with frequency 1:1) and by 33% (with frequency 1:4)
of the drop reached with the cylindrical IAB. After com-
pensating for differences in nominal IAB volume, Shape 1
generally achieved higher Paug over most angles. Newly
shaped IABs could allow for IABP therapy to become
more efficient for patients nursed at the semirecumbent
position. The findings promote the idea of personalized
rather than generalized patient therapy for the achievement
of higher IABP therapeutic efficiency, with a choice of
IAB shape that prioritizes the recovery of those hemody-
namic indices that are more in need of support in the unas-
sisted circulation. Key Words: Intra-aortic balloon
pump—Counterpulsation—Balloon shape—Balloon effi-
cacy—Semirecumbent—Hemodynamics.
Over the past five decades the intra-aortic bal-
loon pump (IABP) has established a successful
track record in delivering minimally invasive
mechanical circulatory support in various clinical
scenarios (1–3). The IAB is inflated at aortic valve
closure and deflated prior to aortic valve opening,
with the electrocardiogram (ECG) or the aortic
pressure waveform used for the synchronization of
the native heart and the device.
The main direct hemodynamic benefits of the
IABP are augmentation in diastolic aortic pressure
(Paug_ao) due to inflation and reduction in end-
diastolic aortic pressure (DedPao) due to deflation.
These effects are achieved through blood volume
displacement upstream the IAB tip, with blood
pushed toward the aortic arch during inflation and
sucked away from the aortic arch during deflation.
It is broadly accepted that Paug_ao and DedPao stim-
ulate enhanced coronary blood flow and improved
unloading of the left ventricle (LV), respectively,
causing in turn an increase in myocardial oxygen
supply and decrease in demand.
Nursing critically ill patients in the semirecum-
bent position (head and torso inclined at angles of
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up to 458) is widely adopted as a potential prophy-
lactic measure against ventilator-associated pneu-
monia (4). In this clinical scenario, the effects of
the upright positioning on other physiological
mechanisms are often not fully appreciated. Angu-
lation has a pronounced effect on the performance
of the IABP and is associated with changes in the
inflation and deflation pattern of the IAB (5–7);
inflation is generally reported to become faster and
deflation to become slower at an angle (6). More-
over, while at the horizontal position the IAB
inflates and deflates uniformly along its length, at
angled positions inflation starts from the tip and pro-
gresses toward the base and, following exactly the
opposite pattern, deflation progresses from base to
tip. These differences in the pattern of inflation and
deflation at angled positions are accompanied by
adverse hemodynamic changes, such as drop in dia-
stolic aortic pressure augmentation (6,8), diastolic
coronary flow (5), and, if the absolute magnitude is
taken into account, drop in end-diastolic aortic pres-
sure reduction as well (6–8).
Relatively few efforts to implement design
changes on the IAB in order to increase blood vol-
ume displacement during inflation and deflation,
and thus improve the overall counterpulsation ben-
efit, have been made, despite the IABP being clini-
cally used for several decades. The addition of an
umbrella-type of valve at the base of the IAB cath-
eter was proposed as a solution for preventing the
retrograde abdominal aortic flow that is generated
during deflation, from interfering with the concomi-
tant antegrade ascending aortic flow which is
responsible for end-diastolic LV unloading (9). A
similar rationale lies behind the design of a dual-
chamber IAB; a distal spherical chamber, con-
nected in-series to the base of a cylindrical IAB
chamber, is inflated early in diastole, occluding the
aorta and thus forcing all blood volume displaced
during the simultaneous inflation of the cylindrical
IAB to move in its entirety toward the aortic root
(10). Various other multichamber IAB designs
have emerged over the years, aiming to improve
inflation and deflation IABP efficacy through the
operating flexibility allowed by chambers con-
nected in-series; some designs consisted of cham-
bers constructed to fit different parts of the aorta
(11), while others allowed inflation/deflation of
each chamber to be controlled independently and
thus enabled full control over the sequence in
which the chambers inflated/deflated (from base to
tip or from tip to base) (12). An enhanced IAB
consisting of internal and external IABs that are
both connected to the same IABP driving system
has also been tested; the internal IAB is positioned
in the descending aorta and the external IAB is
positioned inside a chamber, the output of which
drains through a conduit just upstream the internal
IAB tip (13). This design provided added capacity
for early diastolic aortic pressure augmentation and
end-diastolic LV unloading, delivered directly in
the ascending aorta. A shorter and wider version of
the cylindrical IAB that is currently used clinically
has also been tested very recently with favorable
hemodynamic results (14).
A complete change in IAB shape for the
enhancement of intra-aortic counterpulsation per-
formance was proposed in 2000 by Meyns et al.
(15), who designed an IAB catheter intended to be
advanced to the ascending rather than the descend-
ing aorta, via the femoral artery. The shape of this
IAB was such that it enabled distal occlusion of the
ascending aorta during inflation, in order to support
augmentation in aortic root pressure
In an attempt to tackle the setback of the deteri-
oration in IABP performance observed at angled
positions, two new conical IAB shapes were pre-
sented in 2013 by our group, one with increasing
(TID) and one with decreasing (TDD) diameter
from base to tip (16). These shapes were designed
in order to essentially counteract the negative
effects of the changes in the inflation and deflation
pattern of the cylindrical IAB that occur with
angle. Following in vitro testing these new shapes,
and in particular the TDD, showed potential for
more stable and improved hemodynamic perform-
ance compared to the cylindrical IAB at angles.
However, these new IABs required redesigning in
order to fit in the physiological space that is avail-
able in the human descending aorta.
The aim of the present study is to investigate the
hemodynamic performance of six new IABs, and
compare it to that of a cylindrical IAB. We also
aimed to identify the shapes that had the best
hemodynamic performance during inflation and
during deflation.
MATERIALS AND METHODS
Balloons
Six newly shaped IABs were manufactured by Tel-
eflex (Reading, PA, USA) according to the standard
production process followed for all commercial IAB
products of the company, and using the same materi-
als. The new shapes were based on the traditional
cylindrical shape, but 1/3, 1/2, or 2/3 of their total
length was substituted by a conical segment, with
the joining edge between the cylindrical and conical
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segment blunted in order to minimize the possibility
of additional hemolysis risk, as shown in Fig. 1.
Each of the above three newly shaped IAB mem-
branes produced a lanceolate (“lance”) and an
oblanceolate (“oblance”) configuration (this termi-
nology is borrowed from botanology, where it is
used for the description of leaf shapes), by mounting
the tip and catheter in opposite ways. Overall, in the
resulting new IABs the diameter of the cylindrical
segment varied from 2.4 to 2.7 cm and the total
length of the membrane varied from 23.0 to 23.6 cm.
Oblance configurations with 2/3, 1/3, and 1/2 conical
segments corresponded to Shape 1, Shape 3, and
Shape 5, respectively (Fig. 1). Lance configurations
with 2/3, 1/3, and 1/2 conical segments corresponded
to Shape 2, Shape 4, and Shape 6, respectively
(Fig. 1). The nominal volume of these balloons, when
operating at transmural pressure of 110 mm Hg, was
34 cc.
A standard 40 cc cylindrical IAB (Fiberoptix 8Fr,
Teleflex) was used as a reference for hemodynamic
performance comparisons.
Experimental setup
The IABs were tested in a mock circulation sys-
tem (MCS) which was assembled according to the
methods described in Kolyva et al. (17) and is
shown in Fig. 2. Briefly, the “aortic root” of a real
size silicone rubber aortic model (HemoLab, Eind-
hoven, The Netherlands) with 11 main branches
(left and right coronary, left and right carotid, left
and right subclavian, celiac, left and right renal,
and left and right common iliac arteries) was con-
nected to the “LV” of an extracorporeal left ven-
tricular assist device (BVS 5000 blood pump,
Abiomed Inc., Danvers, MA, USA). The device
simulated the LV and the left atrium, and incorpo-
rated aortic and mitral valve equivalents as well.
The total arterial compliance of the aortic model
was measured in conformance with the method
reported in Ref. (17) and was 1.67 mL/mm Hg,
which was considered ample for the representation
of the human aorta (18). Physiological distribution
of terminal resistance according to published data
(18) was implemented across the model with capil-
lary tubes of different size fitted at the outlets of all
branches. The ends of the “aortic” branches were
attached to a common tube that simulated the
venous system and was connected to an overhead
reservoir open to the air. The loop was closed by
connecting the “left atrium” to the reservoir, which
in turn was filled with enough water to provide
atrial pressure of 15 mm Hg. The use of water as
flowing medium in setups used for IABP testing is
common in the literature (17,19,20).
In the clinical setting the BVS 5000 is driven by
an external console through a pneumatic (air) line.
However, this console did not allow full operator
control over the generated flow profile, neither in
terms of time nor in terms of volume parameters.
Therefore, we used a positive displacement pump
(Placepower, Gorleston, UK) instead, to drive with
water the artificial heart of the MCS. This combina-
tion essentially enabled us to simulate reproducibly
any physiological flow profile, irrespective of IAB
performance or of the operating angle of the MCS.
The pump was set to provide stroke volume of
50 mL, at a heart rate of 58 bpm with diastolic time
fraction (DTF) of 55% (cardiac output 2.9 L/min).
The MCS was assembled on a tilting platform
and could be operated at a range of angles (0–708),
to simulate the semirecumbent position.
IABP settings
The IABs were advanced in the descending aorta
via the “right common iliac artery” and positioned
with the tip just distal to the “left subclavian”
branch, according to conventional clinical practice
(Fig. 2). The IABs were connected to an IABP
(AutoCAT 2 WAVE, Teleflex) via the helium line
that matched more closely their nominal volume.
The IABP was set to counterpulsate with the
artificial heart of the MCS, using the “ECG” out-
put of the hydraulic pump for synchronizing the
two devices. The IABP was set at operating mode
“OPERATOR” and, based on the shape of the
“ECG,” trigger mode “VPACE” was selected. The
onset of inflation was set at 40% and the onset of
Cylindrical
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FIG. 1. Schematic diagram of the cylindrical IAB and the six
newly shaped IABs that were tested. Configurations with
increasing diameter from base to tip and 2/3, 1/3, and 1/2 coni-
cal segments correspond to Shape 1, Shape 3, and Shape 5,
respectively. Configurations with decreasing diameter from base
to tip and 2/3, 1/3, and 1/2 conical segments correspond to
Shape 2, Shape 4, and Shape 6, respectively. The diagram
serves only as a schematic representation of the different
shapes and the relative dimensions between the IABs are not
precise.
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deflation at 75% of the duration of the heart cycle.
This enabled the onset of inflation to coincide with
the closure of the “aortic valve,” and the onset of
deflation to occur early enough to allocate
adequate time for a more lengthy deflation at an
angle (6), while a considerable reduction in end-
diastolic “aortic root” pressure could still be
effected. The end of systole was programmed at
45% in the hydraulic pump. However, due to the
delay involved in the translation of the electronic
triggering of IAB inflation into shuffling helium in
the IAB (21), inflation was required to be triggered
at 40% in order for the IAB to start inflating at
“aortic valve” closure. All IABs were inflated at
full augmentation volume.
Measurements and protocol
Simultaneous pressure (P) and flow (Q) meas-
urements were obtained at the “aortic root” of the
MCS, just distal to the “coronary arteries.” P was
measured with the tip sensor of a solid-state, 3Fr
dual-pressure-sensor-equipped catheter (Mikro-Tip,
Millar Inc., Houston, TX, USA). Q was measured
using a 32-mm ultrasonic perivascular flowprobe
(Transonic Systems Inc., Ithaca, NY, USA). Shuttle
gas pressure (Pshuttle) from the output of the IABP
(as a reference for IAB inflation/deflation timing)
and the “ECG” from the output of the hydraulic
pump were also obtained. All data were sampled at
1000 Hz using a LabVIEW-based acquisition sys-
tem (National Instruments Corporation Ltd., New-
bury, UK). Typical example waveforms recorded
with the cylindrical IAB positioned at 08 are pro-
vided in Fig. 3.
Recordings were made with the MCS at angles 0,
10, 20, 30, and 408 to the horizontal. For each angle,
each IAB was tested sequentially at assistance fre-
quencies 1:1 and 1:4, as representative of full and
weaning IABP support frequencies, respectively.
For every combination of assistance frequency,
IAB shape, and angle, each recording consisted of
approximately 1 min with the IABP on for 1:1 and
2 min for 1:4 assistance frequencies, followed by 1
min with the IABP at standby (“baseline”), and
was repeated twice. All beats recorded with the
IABP on at frequency 1:1, but only every fourth
beat recorded with the IABP on at frequency 1:4,
will show the effect of counterpulsation/IABP sup-
port (“assisted” beats). The latter frequency is not
merely a “time-diluted” mode of 1:1; there is
Venous return
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FIG. 2. Schematic represen-
tation of the mock circulation
system. The “aortic root” of
the aortic model was con-
nected to the “left ventricle” of
an extracorporeal left ventricu-
lar assist device (BVS5000).
Physiological distribution of
terminal resistance was imple-
mented across the model with
capillary tubes of different size
fitted at the outlets of all
“arterial” branches. The ends
of the branches were attached
to a common tube that simu-
lated the venous system and
was connected to an over-
head reservoir open to the air.
The loop was closed by con-
necting the “left atrium” to the
reservoir, which in turn was
filled with enough water to
provide atrial pressure of 15
mm Hg. The artificial heart
was driven by a heart simula-
tor pump. The system was
assembled on a tilting platform
and could be operated at
angles 0–708 to the horizontal.
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evidence suggesting that the therapeutic effect pro-
vided by a 1:4 assisted beat does not match the
hemodynamic benefits delivered by a 1:1 assisted
beat (22).
Data analysis
All data were processed in Matlab (version
R2011b, MathWorks, Natick, MA, USA). For
every recording, the “ECG R-peaks” were detected
and used for marking the onset of each “cardiac”
cycle. Subsequently, segments of 10 consecutive
baseline beats and 10 consecutive beats with the
IABP on (40 for support frequency 1:4) were
selected and stored separately for further analysis.
The P and Q signals were smoothed offline with a
cubic 31-point Savitzky-Golay filter.
Diastolic P augmentation (Paug) and end-diastolic
P reduction (DedP) were calculated for the assisted
beats and taken as indicators of the benefit of
IAB inflation and deflation, respectively. Paug was
defined as the difference between peak diastolic
P and P at the dicrotic notch/onset of inflation (Fig.
3). Subtraction from the end-diastolic P (edP) of
each assisted beat, of the mean edP of the corre-
sponding 10 baseline beats, yielded DedP (Fig. 3).
For each assisted beat, stroke volume (SV), vol-
ume pushed upstream the IAB tip due to inflation
(Vinfl) and volume pulled from upstream the IAB
tip due to deflation (Vdefl) were calculated by inte-
gration of the Q signal with respect to time (Fig. 3).
For the determination of SV, positive systolic
Q was integrated, while the derivation of Vinfl
required the integration of the subsequent negative
diastolic Q. Integration of the positive diastolic
Q yielded Vdefl. For each baseline beat, SV was cal-
culated in the same way as for the assisted beat
(Fig. 3). Parameters Vinfl and Vdefl were used as
secondary markers of IAB inflation and deflation
benefit, while SV enabled the monitoring of the
beat-to-beat consistency of the hydraulic pump.
For the above hemodynamic parameters, aver-
ages were derived from the 20 assisted beats that
were analyzed in total for each combination of
assistance frequency, IAB shape, and angle. To
account for the difference in nominal IAB volume
between the cylindrical and the newly shaped IABs,
the averages of the main IABP parameters of interest
were normalized with respect to the nominal IAB vol-
ume and yielded parameters norm_Paug, norm_DedP,
norm_Vinfl, and norm_Vdefl.
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FIG. 3. Measurements ob-
tained with the cylindrical IAB
positioned at 08, when the
IABP was off (left panel) and
during 1:1 IABP support (right
panel). Top panels: “ECG”
and shuttle gas pressure
(Pshuttle) waveforms; middle
panels: “aortic” flow wave-
form; and bottom panels:
“aortic” pressure waveform.
The flow integrations that
yielded stroke volume (SV),
volume displaced upstream
the IAB tip due to inflation
(Vinfl) and volume displaced
upstream the IAB tip due to
deflation (Vdefl) are shown in
the middle panels. The way
reduction in end-diastolic
“aortic” pressure (DedP) and
diastolic “aortic” pressure
augmentation (Paug) were
derived is illustrated in the
bottom panels.
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Statistics
The values reported are mean6 standard devia-
tion. The statistical analysis was performed in
MLwiN (version 2.33, Centre for Multilevel Model-
ling, University of Bristol, Bristol, UK). For Paug,
DedP, Vinfl, and Vdefl, the following comparisons
were made on the assisted beats: (i) separately for
each IAB, values at 08 were compared to values at
each of the other angles and (ii) separately for each
angle, values with the cylindrical IAB were com-
pared to values with each of the other IABs. These
comparisons were made separately for the two
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FIG. 4. Average data (A) at fre-
quency 1:1 and (B) at frequency
1:4, of the changes in end-diastolic
“aortic” pressure reduction (DedP)
that took place when angle
increased from 0 to 408 in incre-
ments of 108. Data are shown sepa-
rately for each IAB, each point is
the average of 20 beats, and the
error bars indicate standard devia-
tions. For each IAB, the small
matching symbols on top of each
plot indicate statistically significant
differences between 08 and each of
the other angles. Similarly, the small
matching symbols under each plot
denote statistically significant differ-
ences compared to the cylindrical
IAB. Statistical significance was
assumed at P<0.05.
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assistance frequencies; it was outside the scope of
this paper to compare the assistance frequencies to
each other.
The statistical comparisons were performed with
mixed model analysis. A statistical model was gen-
erated, in which the individual processed beats and
the recording repetitions were considered random
effects (for each combination of assistance fre-
quency, IAB shape, and angle). In contrast, the dif-
ferent angles and IAB shapes were considered
fixed effects and all interaction terms between
them were taken into account, if they were signifi-
cant (P< 0.2). Two such models were built, one for
each assistance frequency. Each model was based
on all 700 assisted beats that were analyzed in total
for its corresponding assistance frequency. Allow-
ances for a possible effect of mean P were also
made, to compensate for the possibility that mean
P may vary somewhat (within the range of6 10
mm Hg) when the MCS operated at different
angles. Statistical significance was assumed at
P< 0.05.
RESULTS
End-diastolic pressure reduction
Figure 4A,B presents, for each of the seven IABs
that were tested, the changes observed in DedP
with variations in angle for support frequency 1:1
and 1:4, respectively.
For both assistance frequencies the reduction in
edP that could be achieved with the cylindrical IAB,
compared to baseline, was gradually diminished with
increasing angle. For frequency 1:1, DedP was 70%
less in absolute magnitude at 408 compared to 08
(26.66 1.5 mm Hg at 408 vs. 222.36 0.3 mm Hg at
08, P< 0.05) and for frequency 1:4 this percentage
was 136% (4.66 0.5 mm Hg at 408 vs. 212.86 0.3
mm Hg at 08, P< 0.05). At 1:4, DedP was not only
diminished at 408, but was in fact positive, indicating
that edP increased during IABP support compared
to baseline.
Among the newly shaped IABs tested, Shape 2
consistently achieved, in terms of absolute magni-
tude, larger DedP at angles than the cylindrical
IAB. This DedP was gradually diminished by angle,
but to a lesser degree compared to the cylindrical
IAB. Shape 2 produced a 37% deterioration in
DedP with frequency 1:1 (212.76 0.9 mm Hg at
408 vs. 220.36 0.6 mm Hg at 08, P< 0.05) and 55%
deterioration with frequency 1:4 (24.86 2.4 mm
Hg at 408 vs. 210.76 1.3 mm Hg at 08, P< 0.05) at
408 compared to 08. Both for 1:1 and 1:4 DedP with
Shape 2 was statistically significantly different from
DedP with the cylindrical IAB at all angles but one
(108 at 1:1).
It is noted that the superiority of Shape 2
described above is already evident before any nor-
malization for nominal IAB volume is done. Figure
5A,B demonstrates that after the advantage in
favor of the cylindrical IAB was removed, the
enhanced performance of Shape 2 became even
more pronounced.
Diastolic pressure augmentation
The variations displayed by Paug with changes in
angle for all IABs are shown in Fig. 6A,B for fre-
quencies 1:1 and 1:4, respectively.
Similarly to DedP, the magnitude of Paug gener-
ated by the cylindrical IAB was progressively
reduced with increasing angle for both assistance
frequencies. Between 08 and 40, a 31% drop was
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FIG. 5. Changes in normalised end-diastolic “aortic” pressure
reduction (norm_DedP) when angle increased from 0 to 408 in
increments of 108 (A) at frequency 1:1 and (B) at frequency
1:4. Data are shown for the cylindrical IAB and for Shape 2.
Each point was derived by dividing the corresponding average
DedP with the nominal IAB volume.
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observed at frequency 1:1 (23.86 0.3 mm Hg at 408
vs. 34.36 0.2 mm Hg at 08, P< 0.05) and a 33%
drop at frequency 1:4 (21.16 0.3 mm Hg at 408 vs.
31.76 0.2 mm Hg at 08, P< 0.05).
Among all newly shaped IABs, the shape gener-
ally achieving the highest Paug over all angles was
Shape 1. This augmentation was not greater than
the augmentation generated by the cylindrical IAB
at any angle, except for 408, but it displayed a more
stable behavior with increasing angle, with a 14%
decrease in Paug at frequency 1:1 (24.26 0.4 mm
Hg at 408 vs. 28.06 0.3 mm Hg at 08, P< 0.05) and
11% decrease at frequency 1:4 (23.06 0.5 mm Hg
at 408 vs. 25.76 0.2 mm Hg at 08, P< 0.05) when
angle was increased from 0 to 408. Both for 1:1 and
1:4 Paug with Shape 1 was statistically significantly
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FIG. 6. Average data (A) at fre-
quency 1:1 and (B) at frequency
1:4, of the changes in diastolic
“aortic” pressure augmentation
(Paug) that took place when angle
increased from 0 to 408 in incre-
ments of 108. Data are shown sep-
arately for each IAB, each point is
the average of 20 beats, and the
error bars indicate standard devia-
tions. For each IAB, the small
matching symbols on top of each
plot indicate statistically significant
differences between 08 and each of
the other angles. Similarly, the
small matching symbols under each
plot denote statistically significant
differences compared to the cylin-
drical IAB. Statistical significance
was assumed at P<0.05.
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different from Paug with the cylindrical IAB at all
angles but one (408 at 1:1).
After compensating for differences in nominal
IAB volume, the superiority of Shape 1 over the
cylindrical IAB became more evident, especially at
frequency 1:4 (Fig. 7A,B).
Volumes displaced during inflation and deflation
For all IABs, the normalized values for the varia-
tions observed in Vinfl and Vdefl with changes in angle
are listed in Table 1. Because of the large standard
deviations, the statistical analysis performed on
norm_Vinfl and norm_Vdefl could not yield any statis-
tically significant differences between angles or
IABs. As a result, these parameters were not pivotal
in the determination of the best performing IABs
during deflation and inflation, but rather were used
to corroborate the decision that was made based on
DedP and Paug. Indeed, Shape 2 tended to generate
larger norm_Vdefl than the cylindrical IAB in both
assistance frequencies and all angles, with the excep-
tion of 08 at 1:1 and 408 at 1:4. Similarly, Shape 1
tended to produce the same or larger norm_Vinfl
compared to the cylindrical IAB in both frequencies
and all angles, with the exception of 108 at 1:4.
DISCUSSION
Summary of main findings
The hemodynamic performance of six novel
shaped IABs was assessed and compared against
that of a traditionally shaped cylindrical IAB in a
mock circulation system at a range of operating
angles. The absolute magnitude of parameters Paug
and DedP was gradually diminished with increasing
angle for the cylindrical IAB, in agreement with
published studies (6,8). The performance of the
cylindrical IAB was exceeded during deflation by
Shape 2, even before adjusting for the different
nominal volume between the two IABs. This shape
consistently achieved, in terms of absolute
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FIG. 7. Changes in normalized diastolic “aortic” pressure aug-
mentation (norm_Paug) when angle increased from 0 to 408 in
increments of 108 (A) at frequency 1:1 and (B) at frequency
1:4. Data are shown for the cylindrical IAB and for Shape 1.
Each point was derived by dividing the corresponding average
Paug with the nominal IAB volume.
TABLE 1. Normalized displaced volumes with support
frequency 1:1 and 1:4
Shape 08 108 208 308 408
1:1 Cylindrical norm_Vinfl 66 5 86 5 56 4 86 5 86 6
norm_Vdefl 46 2 36 2 26 2 26 2 26 1
Shape 1 norm_Vinfl 126 10 116 6 106 5 106 5 86 5
norm_Vdefl 46 3 26 1 36 2 26 2 36 3
Shape 2 norm_Vinfl 96 7 66 5 86 4 166 10 86 5
norm_Vdefl 46 4 56 3 36 2 26 2 36 2
Shape 3 norm_Vinfl 136 8 76 5 106 9 136 6 76 8
norm_Vdefl 46 2 36 2 36 1 26 2 26 2
Shape 4 norm_Vinfl 116 10 86 5 86 6 106 8 86 6
norm_Vdefl 56 4 56 3 36 3 26 2 36 3
Shape 5 norm_Vinfl 116 8 156 8 106 6 66 5 106 8
norm_Vdefl 46 2 26 3 26 2 26 2 46 3
Shape 6 norm_Vinfl 126 7 86 5 66 5 96 5 76 4
norm_Vdefl 36 2 46 2 46 3 36 2 26 2
1:4 Cylindrical norm_Vinfl 66 5 76 5 86 6 86 6 66 4
norm_Vdefl 36 2 36 2 36 2 26 2 36 1
Shape 1 norm_Vinfl 116 9 76 5 86 5 96 7 76 6
norm_Vdefl 56 3 36 2 26 2 36 3 26 1
Shape 2 norm_Vinfl 106 6 76 4 66 5 156 8 76 4
norm_Vdefl 46 3 46 2 46 3 46 3 36 2
Shape 3 norm_Vinfl 136 8 66 5 86 5 96 6 76 6
norm_Vdefl 56 3 36 2 36 3 36 3 36 2
Shape 4 norm_Vinfl 86 6 86 8 86 5 116 8 76 5
norm_Vdefl 46 3 66 3 36 2 26 2 26 2
Shape 5 norm_Vinfl 116 7 66 5 56 4 86 6 96 5
norm_Vdefl 46 2 46 2 36 2 26 2 46 4
Shape 6 norm_Vinfl 66 4 96 6 56 3 86 6 86 6
norm_Vdefl 56 2 36 2 56 4 36 2 36 3
The normalized volumes are expressed as a percentage of the
nominal IAB volume. norm_Vinfl: normalized volume pushed
upstream the IAB tip during inflation; norm_Vdefl: normalized
volume pulled from upstream the IAB tip during deflation.
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magnitude, larger DedP at angles than the cylindri-
cal IAB. Although the reduction in DedP of Shape
2 was also gradually diminished with angle, it did
so to a lesser degree than the cylindrical IAB; for
example, this diminishment was only 53% (with
frequency 1:1) and 40% (with frequency 1:4) of
that of the cylindrical IAB, when angle increased
from 0 to 408. During inflation Shape 1 displayed a
more stable behavior with increasing angle com-
pared to the cylindrical IAB; for example, with an
increase in angle from 0 to 408, diastolic “aortic”
pressure augmentation dropped only by 45% (with
frequency 1:1) and by 33% (with frequency 1:4) of
the drop reached with the cylindrical IAB. After
normalizing with respect to the nominal volume of
each IAB, Shape 1 generally achieved higher Paug
over most angles.
Rationale for the new design
At the horizontal position a cylindrical IAB
inflates and deflates uniformly along its length.
However, at angled positions inflation starts from
the tip and progresses toward the base, while defla-
tion progresses in reverse order (5–7). This is due
to the hydrostatic pressure difference along the
IAB length; inflation starts from the IAB end that
is surrounded by lower liquid pressure, and defla-
tion starts from the IAB end that is surrounded by
higher liquid pressure (23).
During inflation of a cylindrical IAB at an angle,
fluid is displaced progressively along the length of
the IAB, as the IAB membrane inflates from tip to
base. This displaced fluid will encounter more
opposition traveling toward the tip than toward the
base of the IAB (as the former is already inflated,
obstructing the passage upstream, while the latter is
still deflated) and as a result fluid will be pushed
gradually toward the base of the IAB. Therefore,
the amount of fluid pushed upstream the tip in the
retrograde direction is reduced compared to the
horizontal position (6). Following the same reason-
ing, during deflation of a cylindrical IAB at an
angle, fluid is sucked progressively along the length
of the IAB, as the IAB membrane deflates from
base to tip. This suction will encounter more oppo-
sition pulling fluid from the tip than from the base
of the IAB (as the former is still inflated, blocking
the passage upstream, whilst the latter is already
deflated). As a result, fluid will be gradually pulled
from the base of the IAB and the amount of fluid
that is pulled from upstream the tip in the ante-
grade direction, is reduced compared to the hori-
zontal position (6). This reduction in the amount of
fluid that is displaced upstream the IAB tip, in the
retrograde direction during inflation and in the
antegrade direction during deflation, can explain
the deterioration in IABP hemodynamic perform-
ance observed at angles.
When IABs with oblance or lance configuration
operate at an angle, inflation will also start from
the tip and progress toward the base, while defla-
tion will start from the base and progress toward
the tip; because this pattern is induced by the
hydrostatic pressure difference along the IAB
membrane, it is reasonable to assume that the same
mechanism will be active irrespective of the shape
of the IAB membrane.
During inflation of a lance IAB at an angle, simi-
larly to a cylindrical IAB, fluid will be displaced
progressively along the length of the IAB, as the
IAB membrane gradually inflates from tip to base.
Contrary to the cylindrical IAB however, while
inflation is propagating along the conical part, this
displaced fluid will, in effect, be driven evenly
toward the tip and the base of the IAB, until infla-
tion reaches the cylindrical segment, where a switch
to the displacement pattern observed with the
cylindrical IAB can be expected. Thus overall, a
lance configuration inflated at an angle should be
able to push more fluid in the retrograde direction
upstream the tip of the IAB during early inflation
(and the same amount of fluid during late inflation)
compared to a cylindrical IAB. During deflation of
a lance IAB at an angle, similarly to a cylindrical
IAB, fluid will be sucked progressively along the
length of the IAB, as the IAB membrane deflates
from base to tip. Also similarly to the cylindrical
IAB, while deflation propagates along the cylindri-
cal segment, this suction will encounter more oppo-
sition pulling fluid from the tip than from the base
of the IAB and as a result fluid will be gradually
pulled from the base of the IAB during the early
part of deflation. This pattern however changes
during the latter part of deflation, when the conical
segment of the IAB starts to deflate; the suction
will, in effect, pull fluid evenly from the tip and the
base of the IAB. Thus overall, a lance configuration
deflated at an angle should be able to pull more
fluid in the antegrade direction upstream the tip of
the IAB during late deflation (and the same
amount of fluid during early deflation) compared
to a cylindrical IAB. Our results confirm this
expectation, indicating the lance configuration with
the longest conical segment (Shape 2) as the new
IAB design that performed optimally during the
deflation phase, according to the DedP results.
The design rationale behind the oblance configu-
rations is rather different. With the cylindrical
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segment located at the tip of the IAB, the advant-
age the lance configuration had over the cylindrical
IAB during early inflation and late deflation might
be lost. The potential advantage of the oblance
design lies on the size of the cylindrical tip, which
has larger diameter than the tip of the cylindrical
IAB. It is possible that when the very tip of the
oblance design inflates at the onset of inflation and
deflates at the end of deflation, due to size alone, it
will push more fluid in the retrograde direction and
pull more fluid in the antegrade direction upstream
the tip, compared to the cylindrical IAB. This pre-
diction seems to be confirmed by our results for the
inflation phase, because the oblance configuration
with the longest conical segment (Shape 1) was
found to provide the most promising outcome
among the newly shaped IABs, according to the
Paug results.
Clinical implications
IABs with shapes that deviate from the tradi-
tional cylindrical shape were found to have
improved hemodynamic performance at angles
compared to a cylindrical IAB, when tested in
vitro. If these results are confirmed by in vivo test-
ing, they would provide evidence that IAB counter-
pulsation therapy may be delivered more efficiently
to patients nursed at the semirecumbent position
when these newly shaped IABs are used. The fact
that the new shape that performed better at infla-
tion (based on parameter Paug) was different from
the new shape that performed better at deflation
(based on parameter DedP) suggests that different
patient groups might benefit from different IAB
shapes. For example, a patient receiving IABP sup-
port as a prophylactic measure during a high-risk
coronary procedure might benefit more by
improved inflation performance, which would
ensure enhanced coronary blood flow augmentation
(Shape 1). Oppositely, a patient in cardiogenic
shock might benefit more by improved deflation
performance, which would in turn provide boosted
LV unloading (Shape 2). These findings promote
the idea of personalized rather than generalized
patient therapy for the achievement of higher
IABP therapeutic efficiency, with a choice of IAB
shape that prioritizes the recovery of those hemo-
dynamic indices that are more in need of support in
the unassisted circulation.
Limitations
A cylindrical IAB of the same size as the newly
shaped IABs was not available, and normalization,
with respect to the nominal IAB volume, was car-
ried out in order to compensate for the fact that
the newly shaped IABs were smaller than the cylin-
drical IAB. The nominal volume was assumed to
be the volume the IABs were able to displace when
inflated at transmural pressure of 110 mm Hg,
which is considered a realistic clinical assumption.
The mean “aortic” pressure in the MCS was
pathophysiological, falling within the hypertensive
spectrum. Nonetheless, it is not anticipated that the
observed trends for any of the hemodynamic
parameters of interest would be different for a
more physiological mean P; when tested statically,
the volumes displaced by each of the IAB mem-
branes during inflation were linear (and parallel
between them) functions of transmural pressure
over a wide range of transmural pressures.
A final limitation of the present experimental
work is the lack of “coronary” flow measurements,
as an additional indicator of inflation performance.
Because of technical constraints, the MCS did not
mimic the mechanism of coronary systolic flow
impediment; hence coronary flow quantification
would not be meaningful.
CONCLUSION
Intra-aortic balloon pumps with new shapes were
less affected, compared to a cylindrical IAB, when
operated at a clinical range of angles to the hori-
zontal. The hemodynamic performance of the cylin-
drical IAB was exceeded during deflation by Shape
2, which was found to consistently achieve, in terms
of absolute magnitude, larger reduction in end-
diastolic pressure at angles than the cylindrical
IAB. Although this reduction was gradually dimin-
ished with angle, it did so to a lesser degree than
the cylindrical IAB; this diminishment was only
53% (with frequency 1:1) and 40% (with frequency
1:4) of that of the cylindrical IAB, when angle
increased from 0 to 408. During inflation Shape 1
displayed a more stable behavior with increasing
angle compared to the cylindrical IAB; with an
increase in angle from 0 to 408, diastolic “aortic”
pressure augmentation dropped only by 45% (with
frequency 1:1) and by 33% (with frequency 1:4) of
the drop reached with the cylindrical IAB. After
compensating for differences in nominal IAB vol-
ume, this shape generally achieved higher augmen-
tation in diastolic “aortic” pressure over most
angles.
These newly shaped IABs could allow for IABP
therapy to become more efficient for patients
nursed at the semirecumbent position. The fact that
the new shape that performed better at inflation
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was different from the new shape that performed
better at deflation suggests that different patient
groups might benefit from different IAB shapes.
These findings promote the idea of personalized
rather than generalized patient therapy for the
achievement of higher IABP therapeutic efficiency,
with a choice of IAB shape that prioritizes the recov-
ery of those hemodynamic indices which are more in
need of support in the unassisted circulation.
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